162 related articles for article (PubMed ID: 33316929)
1. BCG Provides Short-Term Protection from Experimental Cerebral Malaria in Mice.
Witschkowski J; Behrends J; Frank R; Eggers L; von Borstel L; Hertz D; Mueller AK; Schneider BE
Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33316929
[TBL] [Abstract][Full Text] [Related]
2. Coenzyme Q10 exhibits anti-inflammatory and immune-modulatory thereby decelerating the occurrence of experimental cerebral malaria.
Nyariki JN; Kimani NM; Kibet PS; Kinuthia GK; Isaac AO
Mol Biochem Parasitol; 2023 Sep; 255():111579. PubMed ID: 37385350
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
Blank J; Behrends J; Jacobs T; Schneider BE
Infect Immun; 2016 Feb; 84(2):502-10. PubMed ID: 26644378
[TBL] [Abstract][Full Text] [Related]
4. Human ApoE2 protects mice against
Liang R; Rao H; Pang Q; Xu R; Jiao Z; Lin L; Li L; Zhong L; Zhang Y; Guo Y; Xiao N; Liu S; Chen X-F; Su X-z; Li J
mBio; 2023 Oct; 14(6):e0234623. PubMed ID: 37874152
[TBL] [Abstract][Full Text] [Related]
5. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
6. The Deubiquitinating Enzyme Cylindromatosis Dampens CD8
Schmid U; Stenzel W; Koschel J; Raptaki M; Wang X; Naumann M; Matuschewski K; Schlüter D; Nishanth G
Front Immunol; 2017; 8():27. PubMed ID: 28203236
[TBL] [Abstract][Full Text] [Related]
7. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
8. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
9. Live Vaccination with Blood-Stage
Imai T; Ngo-Thanh H; Suzue K; Shimo A; Nakamura A; Horiuchi Y; Hisaeda H; Murakami T
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632518
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
[TBL] [Abstract][Full Text] [Related]
12. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ
Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000
[TBL] [Abstract][Full Text] [Related]
13. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
[TBL] [Abstract][Full Text] [Related]
14. Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
Schmidt KE; Kuepper JM; Schumak B; Alferink J; Hofmann A; Howland SW; Rénia L; Limmer A; Specht S; Hoerauf A
PLoS One; 2018; 13(2):e0192717. PubMed ID: 29438386
[TBL] [Abstract][Full Text] [Related]
15. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection.
Apoorv TS; Babu PP
Cytokine; 2017 Feb; 90():113-123. PubMed ID: 27865203
[TBL] [Abstract][Full Text] [Related]
16. Effects of anti-tau immunotherapy on reactive microgliosis, cerebral endotheliopathy, and cognitive function in an experimental model of cerebral malaria.
Akide Ndunge OB; Shikani HJ; Dai M; Freeman BD; Desruisseaux MS
J Neurochem; 2023 Nov; 167(3):441-460. PubMed ID: 37814468
[TBL] [Abstract][Full Text] [Related]
17. VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.
Canavese M; Dottorini T; Crisanti A
Pathog Glob Health; 2015 Sep; 109(6):255-65. PubMed ID: 26392042
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting the Mammalian target of rapamycin blocks the development of experimental cerebral malaria.
Gordon EB; Hart GT; Tran TM; Waisberg M; Akkaya M; Skinner J; Zinöcker S; Pena M; Yazew T; Qi CF; Miller LH; Pierce SK
mBio; 2015 Jun; 6(3):e00725. PubMed ID: 26037126
[TBL] [Abstract][Full Text] [Related]
19. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.
Nacer A; Movila A; Sohet F; Girgis NM; Gundra UM; Loke P; Daneman R; Frevert U
PLoS Pathog; 2014 Dec; 10(12):e1004528. PubMed ID: 25474413
[TBL] [Abstract][Full Text] [Related]
20. The application of anti-Toso antibody enhances CD8(+) T cell responses in experimental malaria vaccination and disease.
Lapke N; Tartz S; Lee KH; Jacobs T
Vaccine; 2015 Nov; 33(48):6763-70. PubMed ID: 26597034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
